Japan Institute Finds Way To Halve Time To Produce H1N1 Vaccine
This article was originally published in PharmAsia News
Executive SummaryJapanese researchers say they have found a way to enable production of an H1N1 flu vaccine within a three-month period, half the time it now takes. Osaka University's Research Institute for Microbial Diseases, where the research was conducted, says it will build a facility to begin mass-production of its vaccine within four years. With the move, the institute said it should be able to produce enough vaccine within a six-month period to treat 60 million people, five times its current capacity. (Click here for more - a subscription may be required
You may also be interested in...
Nearly 500 shipments of illegal and unapproved prescription drugs and combination medical devices were seized at US borders thanks to Operation Broadsword.
Sanofi follows Janssen in teaming up with HHS' BARDA to develop a COVID-19 vaccine; using technology platform of its Flublok vaccine, Sanofi expects to enter clinical trials in 1 to 1 ½ years.
Biotech licenses drug composition patents from University of Alaska Fairbanks for study in several disease states. Gilead seeks long-acting HIV therapy or prevention with broadly neutralizing antibodies discovered by Rockefeller U.